September 12th, 2016
EpiPens Should Be Less Expensive
Kashif Shaikh, MD
This basic lifesaving medication is cheap to produce. It should not be a way to make a billion dollar profit. Should EpiPens be inexpensive and available? I say yes, and here are my reasons. I am not going to blame Shkreli or Bresch for trying to make money; it’s the system of silence and inaction that I blame. Money, power, corruption, and political influence are the […]
2021-2022 Chief Resident Panel
Abdullah Al-abcha, MD
Mikita Arora, MD
Madiha Khan, DO
Khalid A. Shalaby, MBBCh
Brandon Temte, DO
Resident chiefs in hospital, internal, and family medicine
Learn more about Insights on Residency Training.
NEJM Journal Watch – Recent General Medicine Articles- How Often Does RSV Cause Outpatient COPD Exacerbations?
- Simultaneous vs. Sequential Administration of COVID-19 and Influenza Vaccines
- When to Start Anticoagulation After Ischemic Stroke in Patients with Atrial Fibrillation
- Aortic-Valve Replacement vs. Clinical Surveillance for Asymptomatic Severe Aortic Stenosis
- Do SGLT-2 Inhibitors Lower Risk for Recurrent Nephrolithiasis?